Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · IEX Real-Time Price · USD
0.397
-0.006 (-1.49%)
At close: Jul 19, 2024, 4:00 PM
0.450
+0.053 (13.32%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Sangamo Therapeutics Stock Forecast
SGMO's stock price has decreased by -72.89% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for SGMO stock have an average target of 5.17, with a low estimate of 1.00 and a high estimate of 10. The average target predicts an increase of 1,201.94% from the current stock price of 0.40.
Analyst Consensus: Buy
* Price targets were last updated on May 15, 2024.
Analyst Ratings
The average analyst rating for SGMO stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +1,159.13% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 → $5 | Strong Buy | Reiterates | $3 → $5 | +1,159.13% | Mar 19, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $2 | Hold | Reiterates | $2 | +403.65% | Mar 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 | Strong Buy | Maintains | $3 | +655.48% | Mar 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +655.48% | Feb 12, 2024 |
Financial Forecast
Revenue This Year
41.97M
from 176.23M
Decreased by -76.18%
Revenue Next Year
87.72M
from 41.97M
Increased by 108.99%
EPS This Year
-0.56
from -1.48
EPS Next Year
-0.20
from -0.56
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 99.8M | 243.6M | 161.7M | 274.1M | 619.6M |
| Avg | 42.0M | 87.7M | 107.2M | 188.4M | 338.1M |
| Low | 1.9M | 25.9M | 66.6M | 83.2M | 134.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -43.4% | 480.4% | 84.3% | 155.6% | 228.9% |
| Avg | -76.2% | 109.0% | 22.2% | 75.7% | 79.5% |
| Low | -98.9% | -38.4% | -24.0% | -22.3% | -28.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.24 | 0.22 | 0.02 | 0.24 | 1.05 |
| Avg | -0.56 | -0.20 | -0.11 | 0.09 | 0.52 |
| Low | -0.75 | -0.61 | -0.21 | -0.11 | 0.01 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 1,087.3% |
| Avg | - | - | - | - | 492.0% |
| Low | - | - | - | - | -88.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.